Description
Seeking adults with Stage III or IV melanoma skin cancer that will be treated with surgery for a study of an investigational drug combination.
Overview
Participants in this study will be randomly assigned to get either the usual immunotherapy treatment or the investigational drug combination prior to and following melanoma removal surgery. The drugs are given as an IV infusion on 3-week cycles for 18 cycles starting 9 weeks before surgery and ending after about a year.
What we're hoping for
We are studying whether an investigational drug combination is better, worse or the same as the usual immunotherapy before and following surgery for Stage III or IV melanoma skin cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT06190951